Compounds > 1,2,3,4-tetrahydroquinoline
Page last updated: 2024-08-25

1,2,3,4-tetrahydroquinoline and Breast Cancer

1,2,3,4-tetrahydroquinoline has been researched along with Breast Cancer in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Ambudkar, SV; Bernal, CC; Bohórquez, ARR; Kita, DH; Kronenberger, T; Mendez-Sánchez, SC; Poso, A; Tonduru, AK; Valdameri, G; Vesga, LC; Zattoni, IF1
Becerra-Martínez, E; Bello, M; Correa-Basurto, J; Fragoso-Vázquez, MJ; García-Sanchéz, JR; García-Vázquez, JB; Martínez-Ruíz, G; Méndez-Luna, D; Zacarías-Lara, OJ1
Camacho, ME; Campos, JM; Carrión, MD; Fernández-Sáez, N; Rubio-Ruiz, B; Unciti-Broceta, A1
Arenas, DR; Arvelo, F; Kouznetsov, VV; Muñoz, A; Sojo, F1

Other Studies

4 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Breast Cancer

ArticleYear
Tetrahydroquinoline/4,5-Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2).
    ChemMedChem, 2021, 09-06, Volume: 16, Issue:17

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Isoxazoles; Models, Molecular; Molecular Structure; Neoplasm Proteins; Quinolines; Structure-Activity Relationship

2021
Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
    Anti-cancer agents in medicinal chemistry, 2019, Volume: 19, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Models, Molecular; Molecular Structure; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Thermodynamics; Tumor Cells, Cultured

2019
Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents.
    Future medicinal chemistry, 2019, Volume: 11, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Halogenation; HCT116 Cells; Humans; MCF-7 Cells; Purines; Quinolines; Structure-Activity Relationship

2019
Cytotoxic effects of new trans-2,4-diaryl-r-3-methyl-1,2,3,4-tetrahydroquinolines and their interaction with antitumoral drugs gemcitabine and paclitaxel on cellular lines of human breast cancer.
    Chemico-biological interactions, 2011, Feb-01, Volume: 189, Issue:3

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Deoxycytidine; Drug Interactions; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gemcitabine; Humans; Paclitaxel; Quinolines

2011